A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
about
Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.Inhaled iloprost in pulmonary arterial hypertension.Clinical presentation, differential diagnosis, and vasodilator testing of pulmonary hypertension.Novel therapeutics for the treatment of paediatric pulmonary arterial hypertension.Development of agents for the treatment of systemic sclerosis.Inhaled nitric oxide in cardiology.The role of inhaled prostacyclin in treating acute respiratory distress syndrome.New treatments for pulmonary arterial hypertension.Inhaled nitric oxide: more than a selective pulmonary vasodilator.Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.Acute hemodynamic effects of nebulized iloprost via the I-neb Adaptive Aerosol Delivery system in pulmonary hypertension.Acute right ventricular failure--from pathophysiology to new treatments.Iloprost for idiopathic pulmonary arterial hypertension.Iloprost inhalation solution for the treatment of pulmonary arterial hypertension.Advances in the medical treatment of pulmonary hypertension.Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertensionImprovement in right ventricular function during reversibility testing in pulmonary arterial hypertension: a case report.Therapeutic targets in neonatal pulmonary hypertension: linking pathophysiology to clinical medicine.The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.Inhaled iloprost for therapy in pulmonary arterial hypertension.Intensive care unit management of patients with severe pulmonary hypertension and right heart failure.Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension.Managing an acutely ill patient with pulmonary arterial hypertension.Management of pulmonary hypertension and right heart failure in the intensive care unit.Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation.Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.Iloprost in pulmonary hypertension.Inhalative iloprost - pharmacology and clinical application.Improved ventricular function during inhalation of PGI(2) aerosol partly relies on enhanced myocardial contractility.Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension.Iloprost for children with pulmonary hypertension after surgery to correct congenital heart disease.Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension.Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation.Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation.Management of acute heart failure in adult patients with congenital heart disease.
P2860
Q24236378-E3DEF305-741B-44F6-B59C-46A86B148B02Q24240827-3A9D8526-9645-4FC8-A2DB-DD5DBDFD59F7Q24815216-21FC9818-36D7-4C55-86BD-7679F213BBF9Q30437211-340FFCEF-709E-4F65-9C3A-3C20D884B5EBQ33155179-B89E0569-6021-49F6-A96E-C874EC74014BQ34232006-66AD8DD0-43DF-44AE-A2C9-57CA0FC48D19Q34481552-F1B5A584-5088-450D-B5CF-A823896EF9AFQ34481821-2E578D81-2A46-4066-B723-4C5AAE7F3BC7Q34490411-00B4092C-4C16-496E-8AB0-A682CB1F9DC9Q34625826-3C6C11FE-D251-4998-A1A9-321AA1A3149EQ34792514-C85420B4-8251-4895-BB31-7B5AFBEA913DQ35035923-942B53B6-E540-48F9-BD8C-1B701A933117Q35517573-C680693D-CEDB-4940-80B9-317174F7969BQ35584099-A8E14B25-35CD-46A7-B369-723208FE9A8DQ36107191-15888A52-B64F-4197-A0D4-21FF27D3B445Q36249942-EC2C61C0-0A40-4FA3-8A4D-E051741F9A3EQ36420236-29F9DF6F-DE5B-40CD-89A1-C6C827E2C3C6Q37070945-6B6C48B8-881C-4B21-993F-CC9A423CC25CQ37117210-8681DFBF-378B-4440-8E82-B524EF9D7A2AQ37754900-A3EE4683-7D74-4788-A467-60258767B60CQ37837276-2EAD0405-8F1A-424E-A08C-064E0F593A90Q37867662-EB2BFFF8-4387-4EF9-9E4A-57D413458EBBQ37893845-0559DDEC-F4DA-4AFF-993E-01EA345C25B5Q37944298-8A78159A-9453-4FC1-BA46-3A2E1FAB1894Q37960635-A5A22DD2-8C3B-4880-803A-C0768B38AD29Q38077799-F5926231-2BB1-4298-A3DB-2C3362AAFDAFQ38400728-20FF31D0-EDB9-4EEF-B548-09993E80AA6DQ38669078-B3EA7692-53C9-4A6D-B9F7-19ECE8725603Q39329647-90AA4210-E05C-4D18-A1E7-06F3413342B5Q39412753-DC1B8652-A02E-4D2D-B9C0-211896126074Q40465480-852D0C2F-36D6-4C73-95E9-CD0BCA4CC131Q43061658-35B1E9D7-315C-4632-BB15-54418D426786Q43296455-CEFF6770-1167-4142-BDD2-8641406830EEQ46428037-9FFF3230-5D30-4717-94AB-49492B5681EAQ46477683-90806809-EEC3-4C1F-BDB2-139874D6C4BCQ46492866-0BBBA59D-8B4B-4039-8905-C7B34B5B59A5Q46604316-C97B5BDC-F6D7-4CF6-996F-6D0E3B1DEAF4Q46686053-9E546AE4-2AF9-4B01-A55C-ACA95428DE36Q46956327-FB47803C-C512-4856-95BB-B18660145180Q47249280-0651BCC6-B484-4359-865E-4D72394D536C
P2860
A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
description
im Januar 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2000
@uk
name
A comparison of the acute hemo ...... primary pulmonary hypertension
@en
A comparison of the acute hemo ...... primary pulmonary hypertension
@nl
type
label
A comparison of the acute hemo ...... primary pulmonary hypertension
@en
A comparison of the acute hemo ...... primary pulmonary hypertension
@nl
prefLabel
A comparison of the acute hemo ...... primary pulmonary hypertension
@en
A comparison of the acute hemo ...... primary pulmonary hypertension
@nl
P2093
P50
P1476
A comparison of the acute hemo ...... ension. German PPH study group
@en
P2093
P304
P356
10.1016/S0735-1097(99)00494-5
P407
P577
2000-01-01T00:00:00Z